Allergan plc (NYSE: AGN) is a large market cap stock with a market cap of 100209.73. It is in the Drugs – Generic industry and sector Healthcare, with a current P/E of *TBA, a forward P/E of 14.33 and EPS of -5.63. At a stock price of 254.97 (1.68%) it has a dividend yield of *TBA.
EPS growth for the last five years have been -50.40%, more recently this last year it has grown by 23.00%. The next year growth is going to be about 23.46% and more long-term 10.80% after five years. EPS growth quarter over quarter is 91.80%. Sales growth for the past five years have been 33.40% and sales growth quarter over quarter is -44.20%.
For performance, Allergan plc the past week has seen a gain of 0.72%. For the last month performance for Allergan plc is 7.15%. While the last quarter is 16.73% and half year, -10.34%. Finally for the year, performance is -25.13%.
The 52-week high for Allergan plc, is at -24.79%, and for the 52-week low it comes to a value of 30.42%. The 20-day simple moving average is 6.13% and -4.94% for the 200-day simple moving average.
Volatility for the week is at 2.50%, and for the month it is 1.93%. Allergan plc, has a target price of 291.44.
In terms of debt, long term debt/equity is 0.53, and for total debt/equity Allergan plc has 0.59. The gross margin is 71.80%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is 1 and the quick ratio is 0.9.
Insider ownership is at 0.10%, with instituitional ownership at 90.30%. Allergan plc has a payout ratio of *TBA. With the total shares outstanding coming to 399.64. The shares float is 394.89, with the float short at 1.44%, with short ratio coming to 1.58.
In terms of returns, the return on assets see Allergan plc, get *TBA, with its returns on investment at -1.30%. Return on equity is *TBA. So will the investors see the target price of 291.44, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.